1. [Intensive hospital monitoring of Shuxuening injection in 30 209 cases].
- Author
-
Jiang JJ, Xie YM, Zhang Y, Li MQ, Zhao YB, Wen ZH, Li XL, Yi DH, and Zhang YK
- Subjects
- Humans, Injections, Drugs, Chinese Herbal adverse effects, Product Surveillance, Postmarketing
- Abstract
In order to obtain the characteristics and incidence of adverse reactions of Shuxuening injection (Xingxue), the design method of a multi-center, large sample intensive monitoring in the hospitals was adopted. The hospitalized patients with use of Shuxuening injection from 27 medical institutions were enrolled as the research subjects to monitor their entire process of treatment cycle. The main content of monitoring included the patients' general information, diagnostic information, medication information, and adverse event information. A total of 30 209 patients with Shuxuening injection were enrolled; adverse reactions occurred in 34 cases, with an incidence of 0.113%, which belonged to the rare adverse reactions. Adverse reactions were characterized by headache, dizziness, pruritus, palpitations, nausea, et al. All the above results showed that Xingxue Shuxuening injection had high safety in clinical application., Competing Interests: The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose., (Copyright© by the Chinese Pharmaceutical Association.)
- Published
- 2017
- Full Text
- View/download PDF